BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33694175)

  • 21. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors.
    Pornprasertsud N; Niparuck P; Kidkarn R; Puavilai T; Sirachainan N; Pakakasama S; Hongeng S; Jootar S; Ungkanont A
    J Clin Apher; 2015 Dec; 30(6):329-34. PubMed ID: 25663039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood CD34+ cell enumeration as a predictor of apheresis yield: an analysis of more than 1,000 collections.
    Gambell P; Herbert K; Dickinson M; Stokes K; Bressel M; Wall D; Harrison S; Prince HM
    Biol Blood Marrow Transplant; 2012 May; 18(5):763-72. PubMed ID: 22227589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.
    Park KU; Kim SH; Suh C; Kim S; Lee SJ; Park JS; Cho HJ; Kim KW; Lee K; Kim HJ; Park J; Joo Min Y; Kim JG; Kim T; Lee JH; Kim SB; Kim SW; Lee KH; Lee JS; Kim WK; Park CJ; Chi HS
    Am J Hematol; 2001 May; 67(1):42-7. PubMed ID: 11279656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plerixafor added to G-CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR-alpha/beta depletion in pediatric haploidentical and genoidentical donors failing to mobilize with G-CSF alone.
    Kurnikova E; Trakhtman P; Pershin D; Ilyushina M; Khismatullina R; Maschan M; Novichkova G; Maschan A
    J Clin Apher; 2021 Aug; 36(4):547-552. PubMed ID: 33682959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of plerixafor in hematopoietic progenitor cell collection in pediatric patients: a single center experience.
    Pham HP; Patel N; Semedei-Pomales M; Bhatia M; Schwartz J
    Cytotherapy; 2012 Apr; 14(4):467-72. PubMed ID: 22339604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.
    Kozuka T; Ikeda K; Teshima T; Yoshida C; Shinagawa K; Kojima K; Matsuo K; Bessho A; Sunami K; Hiramatsu Y; Maeda Y; Noguchi T; Yamamoto K; Fujii N; Imai T; Kusumoto KK; Masuda K; Takenaka K; Ishimaru F; Niiya K; Koide N; Tanimoto M; Harada M
    Transfusion; 2004 Apr; 44(4):526-32. PubMed ID: 15043568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of haematopoietic progenitor cell counting with the Sysmex
    Dima F; Barison E; Midolo M; Benedetti F; Lippi G
    Blood Transfus; 2020 Jan; 18(1):67-76. PubMed ID: 31403932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
    Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use.
    Veltri L; Cumpston A; Shillingburg A; Wen S; Luo J; Leadmon S; Watkins K; Craig M; Hamadani M; Kanate AS
    Cytotherapy; 2015 Dec; 17(12):1785-92. PubMed ID: 26475754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection.
    Yu J; Leisenring W; Fritschle W; Heimfeld S; Shulman H; Bensinger WI; Holmberg LA; Rowley SD
    Bone Marrow Transplant; 2000 Jun; 25(11):1157-64. PubMed ID: 10849528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Hematopoietic Progenitor Cell Count as an Indicator for Optimal Timing of Peripheral Stem Cell Harvest in Clinical Practice.
    Tanaka H; Ishii A; Sugita Y; Shimizu R; Sato F; Sakuma Y; Iwai R; Kakuta S
    J Clin Exp Hematop; 2017; 56(3):150-159. PubMed ID: 28331129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield.
    Yu J; Leisenring W; Bensinger WI; Holmberg LA; Rowley SD
    Transfusion; 1999 May; 39(5):442-50. PubMed ID: 10335991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Peripheral monocyte counts at first collection of allo-grafts predicts amount of CD34(+) cells in mixture of rhG-CSF primed bone marrow and mobilized peripheral stem cell grafts].
    Chang YJ; Zhao XY; Huo MR; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):146-50. PubMed ID: 19236767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34(+) measurements and timing of leukaphereses.
    Oelschlaegel U; Bornhaeuser M; Thiede C; Ehninger G; Hoelig K
    Cytotherapy; 2003; 5(5):414-9. PubMed ID: 14578103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells.
    Pollard Y; Watts MJ; Grant D; Chavda N; Linch DC; Machin SJ
    Br J Haematol; 1999 Aug; 106(2):538-44. PubMed ID: 10460620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
    Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of CD34(+) cell yield in hematopoietic cell products from children by peripheral blood CD34(+) cell counts.
    Rujkijyanont P; Hipps J; Gan K; Yang J; Wang C; Geiger TL; Eldridge PW; Leung W
    Cytotherapy; 2012 Apr; 14(4):473-82. PubMed ID: 22420835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.
    Panch SR; Yau YY; Kang EM; De Ravin SS; Malech HL; Leitman SF
    Transfusion; 2015 Feb; 55(2):265-74. PubMed ID: 25143186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A Single-Center Analysis of the Use of G-CSF Combined with Plerixafor to Mobilize Peripheral Blood Hematopoietic Stem Cell from Healthy Related Donors in Allogeneic Hematopoietic Stem Cell Transplantation].
    Chen J; Yuan LL; Zhang X; Qiao JL; Yin QX; Zhang YM; Yang XL; Cao XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):286-291. PubMed ID: 35123641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.
    Bertani G; Santoleri L; Martino M; Fedele R; Moscato T; Marenco P; Grillo G; Zucchetti E; Lotesoriere I; Lando G; Cesana C; Cairoli R; Rossini S
    Transfusion; 2014 Aug; 54(8):2028-33. PubMed ID: 24588265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.